Literature DB >> 14557341

MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.

Matthew R Reynolds1, Mark E Josephson.   

Abstract

Mesh：

Year:  2003        PMID： 14557341     DOI： 10.1161/01.CIR.0000086777.82110.F5

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

Review 1.  [ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection].

Authors:  J Neuzner; R Gradaus
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-06-04

2.  Serum apolipoprotein B is inversely associated with eccentric left ventricular hypertrophy in peritoneal dialysis patients.

Authors:  Min Ye; Yanqiu Liu; Haoyu Wang; Na Tian; Wei Li; Wei He; Hong Lin; Rui Fan; Cuiling Li; Donghong Liu; Fengjuan Yao
Journal:  Int Urol Nephrol       Date:  2017-11-10       Impact factor: 2.370

3.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Authors:  Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

4.  Ventricular arrhythmias after LV remodelling: surgical ventricular restoration or ICD?

Authors:  M DiDonato; M Sabatier; V Dor; G Buckberg
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

5.  Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction.

Authors:  Yee Guan Yap; Trinh Duong; J Martin Bland; Marek Malik; Christian Torp-Pedersen; Lars Køber; Mark M Gallagher; A John Camm
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

Review 6.  The role of prophylactic implantable cardioverter defibrillators in heart failure: recent trials usher in a new era of device therapy.

Authors:  Timothy D Brennan; Garrie J Haas
Journal:  Curr Heart Fail Rep       Date:  2005-03

7.  Could it be Quetiapine-induced Peripartum Cardiomyopathy?

Authors:  Mandeep Kaler; Rameen Shakur; Hazel I Learner; Andrew Deaner; Richard J Howard
Journal:  Obstet Med       Date:  2013-03-01

8.  Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.

Authors:  Mohamad El Moheb; Johny Nicolas; Assem M Khamis; Ghida Iskandarani; Elie A Akl; Marwan Refaat
Journal:  Cochrane Database Syst Rev       Date:  2018-12-08

9.  Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI).

Authors:  Massimo Santini; Maurizio Russo; Gianluca Botto; Maurizio Lunati; Alessandro Proclemer; Boris Schmidt; Ali Erdogan; Erhard Helmling; Werner Rauhe; Martin Desaga; Elisabetta Santi; Marc Messier; Giuseppe Boriani
Journal:  Europace       Date:  2009-01-09       Impact factor: 5.214

10.  The need for studies to evaluate the reproducibility of the T-wave alternans (TWA), and the rationale for a correction index of the TWA.

Authors:  John E Madias
Journal:  Indian Pacing Electrophysiol J       Date:  2007-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.